A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM

Monthly eligibility and recruitment rates per month of patients with multiple myeloma

is defined as the number of patients with MM that satisfied entry criteria per study site/month)

Time frame: Up to 12 months

User average weekly log-in rates over the duration of follow-up from patients with MM and HCPs

is defined as the number of times a user attempts to log in/week

Time frame: Up to 6 months

Duration of follow-up

is defined as the mean, median, and range of time from each user's first login to his or her last login to the Patient App or to the HCP Portal

Time frame: Up to 6 months

Patient-reported outcome completion rates

Is defined as the number of data points that are completed divided by the number of data points that could have been completed at each specified timepoint, relative to the enrollment date of each participant

Time frame: Up to 6 months

Frequency of user access by feature and by month, relative to the enrollment date of each participant

Is defined as how often patients access various features of the app, per month relative to the enrollment date of each participant

Time frame: Up to 6 months

Percentage of patients for whom the HCPs complete the 6-month assessments

is defined as number of patients for whom HCPs provided 6-month assessments \[eg, disease response assessments\] divided by the number of patients for whom HCPs provided baseline data)

Time frame: up to 18 months

Patient empowerment and self-efficacy measured by CASE-Cancer

The instrument consists of 3 subscales: understanding and participating in care, maintaining a positive attitude, and seeking and obtaining information. All items are scored on a range of 1 to 4 from strongly disagree to strongly agree, with higher score indicating better empowerment